- Yim JY, Yang SJ, Yim JM, Song MY, Rho HW, Yim SK, Han YH, Jeon SY, Kim HS, Yhim HY, Lee NR, Song EK, Kwak JY, Sohn MH, Yim CY. Lymphocyte-mediated macrophage apoptosis during IL-12 stimulation.
Cytokine. 2013 Oct 64(1):62-70.
- Song EK, Yim JM, Yim JY, Song MY, Rho HW, Yim SK, Han YH, Jeon SY, Kim HS, Yhim HY, Lee NR, Kwak JY, Sohn MH, Park HS, Jang KY, Yim CY.
Glutamine protects mice from acute graft-versus-host disease (aGVHD). Biochem Biophys Res Commun. 2013 May 24 435(1):94-9.
- Yhim HY, Jang MJ, Kwak JY, Yim CY, Choi WI, Lee YC, Lee JO, Lee KW, Bang SM, Kim SH, Kim YK, Chang HJ, Oh D Korean Venous Thromboembolism Working Party.
The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after
the diagnosis of index VTE. Thromb Res. 2013 Apr 131(4):e133-40.
- Kim JS, Jeong YJ, Sohn MH, Jeong HJ, Lim ST, Kim DW, Kwak JY, Yim CY. Usefulness of F-18 FDG PET/CT in subcutaneous panniculitis-like T cell lymphoma:
disease extent and treatment response evaluation. Radiol Oncol. 2012 Dec 46(4):279-83.
- Suh B, Shin DW, Kim SY, Park JH, Chang WY, Lim SP, Yim CY, Cho BL, Park EC, Park JH. Mode of primary cancer detection as an indicator of screening practice
for second primary cancer in cancer survivors: a nationwide survey in Korea. BMC Cancer. 2012 Nov 26 12:557.
- Song EK, Yim JM, Yim JY, Song MY, Rho HW, Yim SK, Jeon SY, Kim HS, Yhim HY, Lee NR, Kwak JY, Sohn MH, Park HS, Jang KY, Yim CY. Rosiglitazone prevents
graft-versus-host disease (GVHD). Transpl Immunol. 2012 Oct 27(2-3):128-37.
- Choi YH, Oh SC, Kim JS, Nam SH, Kim BS, Cho SH, Chung IJ, Song EK, Yim CY,
Baek JH, Jeung HC, Hong YS, Yang SH, Kang HJ. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment
: a Korean Cancer Study Group Protocol ST06-02. Cancer Chemother Pharmacol. 2012 Nov 70(5):665-72.
- Yhim HY, Kim HS, Lee NR, Song EK, Kwak JY, Yim CY. Bilateral subdural hemorrhage as a serious adverse event of dasatinib in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia. Int J Hematol. 2012 May 95(5):585-7.
- Yhim HY, Lee NR, Song EK, Yim CY, Jeon SY, Shin S, Kim JA, Kim HS, Cho EH, Kwak JY. Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response. Leuk Res. 2012 Jun 36(6):689-93.
- Lee NR, Yhim HY, Yim CY, Kwak JY, Song EK. Sunitinib-induced hyperammonemic encephalopathy in gastrointestinal stromal tumors. Ann Pharmacother. 2011 Oct 45(10):e56.
- Sohn MH, Jeong YJ, Jeong HJ, Lim ST, Kim DW, Chung MJ, Yim CY. F-18 FDG PET/CT findings of huge cholesterol granuloma in multiple ribs. Clin Nucl Med. 2011 Oct 36(10):942-4.
- Jeong YJ, Sohn MH, Lim ST, Kim DW, Jeong HJ, Yim CY. F-18 FDG PET/CT imaging of metastatic extrarenal Wilms tumor arising in the inguinal canal. Clin Nucl
Med. 2011 Jun 36(6):475-8.
- Song MY, Yim JY, Yim JM, Kang IJ, Rho HW, Kim HS, Yhim HY, Lee NR, Song EK, Kwak JY, Sohn MH, Yim CY. Use of curcumin to decrease nitric oxide production during the induction of antitumor responses by IL-2.
J Immunother. 2011 Mar 34(2):149-64.
- Jeong YJ, Sohn MH, Lim ST, Kim DW, Jeong HJ, Jang KY, Yim CY. Osteoblastoma in the nasal cavity: F-18 FDG PET/CT and Tc-99m MDP 3-phase bone scan findings with pathologic correlation.
Clin Nucl Med. 2011 Mar 36(3):214-7.
- Yhim HY, Lee NR, Song EK, Kwak JY, Lee ST, Kim JH, Kim JS, Park HS, Chung IJ, Shim HJ, Hwang JE, Kim HR, Nam TK, Park MR, Shim H, Park HS, Kim HS, Yim CY.
The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy. Int J Cancer. 2011 Oct 1 129(7):1752-60.